Drug intelligence / Profile preview

ambrosia ambrosioides pollen

Development stage
Unknown
Lead developer
ALK Abelló
Administration
Subcutaneous, Topical
01

Overview

Ambrosia ambrosioides pollen extract is an allergenic biologic used for both the diagnosis and treatment of ragweed-induced hypersensitivity. As a therapeutic agent in allergen immunotherapy (AIT), it is administered in gradually increasing doses to induce immunological tolerance. The mechanism involves a shift in the immune response from a Th2-mediated allergic profile to a Th1 or regulatory T-cell (Treg) profile. This modulation leads to the expansion of Treg populations, increased secretion of anti-inflammatory cytokines such as interleukin-10 (IL-10), and the production of allergen-specific IgG4 antibodies. These IgG4 antibodies act as 'blocking antibodies' that compete with IgE for allergen binding, thereby preventing the degranulation of mast cells and basophils. In diagnostic applications, the extract is used in skin prick testing to identify patients with specific IgE-mediated sensitivity to canyon ragweed.

Other names
Canyon ragweed pollenChicura pollen
02

Targets

High-affinity immunoglobulin epsilon receptor-bound Immunoglobulin E complex

Beyond the preview

Go deeper on ambrosia ambrosioides pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ambrosia ambrosioides pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call